학술논문
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial
Document Type
Letter
Author
Source
In: American Journal of Hematology . (American Journal of Hematology, April 2023, 98(4):E84-E87)
Subject
Language
English
ISSN
10968652
03618609
03618609